Marksans Pharma Limited (NSE:MARKSANS)
India
· Delayed Price · Currency is INR 246.95
+4.15 (1.71%)
Jun 25, 2025, 3:29 PM IST
Marksans Pharma Employees
Marksans Pharma had 1,141 employees as of March 31, 2024. The number of employees increased by 289 or 33.92% compared to the previous year.
Employees
1,141
Change (1Y)
289
Growth (1Y)
33.92%
Revenue / Employee
22.99M INR
Profits / Employee
3.34M INR
Market Cap
110.03B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Mar 31, 2024 | 1,141 | 289 | 33.92% |
| Mar 31, 2023 | 852 | -38 | -4.27% |
| Mar 31, 2022 | 890 | -248 | -21.79% |
| Mar 31, 2021 | 1,138 | -12 | -1.04% |
| Mar 31, 2020 | 1,150 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Sun Pharmaceutical Industries | 43,000 |
| Divi's Laboratories | 9,741 |
| Cipla | 27,764 |
| Apollo Hospitals Enterprise | 83,147 |
| Zydus Lifesciences | 26,921 |
| Mankind Pharma | 19,540 |
| Aurobindo Pharma | 26,015 |
| Fortis Healthcare | 12,088 |
Marksans Pharma News
- 6 days ago - Marksans Pharma’s UK subsidiary secures approval for Oxybutynin Hydrochloride oral solution - Business Upturn
- 14 days ago - Marksans Pharma shares jump 3% after large block deal worth Rs 257 crore - Business Upturn
- 14 days ago - Marksans Pharma Block Deal: Over 1 crore shares worth Rs 257 crore change hands at Rs 249.95 per share - Business Upturn
- 26 days ago - Marksans Pharma’s subsidiary Relonchem gets UK MHRA approval for Metformin Hydrochloride Oral Solution - Business Upturn
- 5 weeks ago - Marksans Pharma’s UK arm gets marketing approval for Sennosides 7.5 mg tablets - Business Upturn
- 5 weeks ago - Marksans Pharma’s UK subsidiary Relonchem gets UKMHRA nod for Gabapentin oral solution - Business Upturn
- 2 months ago - Marksans Pharma’s subsidiary receives one USFDA observation after cGMP inspection at New York facility - Business Upturn
- 3 months ago - Marksans Pharma shares up nearly 4% as company secures Australian TGA approval for Goa facility - Business Upturn